Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 229 to 233 of 233 entries
Sorted by: Best Match Show Resources per page
Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Trobaugh-Lotrario A, Katzenstein HM, Ranganathan S, Lopez-Terrada D, Krailo MD, Piao J, Chung N, Randazzo J, Malogolowkin MH, Furman WL, McCarville EB, Towbin AJ, Tiao GM, Dunn SP, Langham MR, McGahren ED, Feusner J, Rodriguez-Galindo C, Meyers RL, O'Neill AF, Finegold MJ.
PMID: 34874751
J Clin Oncol. 2021 Dec 07;JCO2100803. doi: 10.1200/JCO.21.00803. Epub 2021 Dec 07.

PURPOSE: Small cell undifferentiated (SCU) histology in hepatoblastoma (HB) tumors has historically been associated with a poor prognosis. Tumors from patients enrolled on Children's Oncology Group (COG) study AHEP0731 underwent institutional and central pathologic review for identification of SCU...

Cite
Trobaugh-Lotrario A, Katzenstein HM, Ranganathan S, et al. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. J Clin Oncol. 2021;JCO2100803doi: 10.1200/JCO.21.00803.
Trobaugh-Lotrario, A., Katzenstein, H. M., Ranganathan, S., Lopez-Terrada, D., Krailo, M. D., Piao, J., Chung, N., Randazzo, J., Malogolowkin, M. H., Furman, W. L., McCarville, E. B., Towbin, A. J., Tiao, G. M., Dunn, S. P., Langham, M. R., McGahren, E. D., Feusner, J., Rodriguez-Galindo, C., Meyers, R. L., O'Neill, A. F., & Finegold, M. J. (2021). Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, JCO2100803. https://doi.org/10.1200/JCO.21.00803
Trobaugh-Lotrario, Angela, et al. "Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. (2021): JCO2100803. doi: https://doi.org/10.1200/JCO.21.00803
Trobaugh-Lotrario A, Katzenstein HM, Ranganathan S, Lopez-Terrada D, Krailo MD, Piao J, Chung N, Randazzo J, Malogolowkin MH, Furman WL, McCarville EB, Towbin AJ, Tiao GM, Dunn SP, Langham MR, McGahren ED, Feusner J, Rodriguez-Galindo C, Meyers RL, O'Neill AF, Finegold MJ. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee. J Clin Oncol. 2021 Dec 07;JCO2100803. doi: 10.1200/JCO.21.00803. Epub 2021 Dec 07. PMID: 34874751.
Copy Download .nbib Format: NLM
Diagnostic accuracy and clinical impact of [18F]FET PET in childhood CNS tumors.

Neuro-oncology

Marner L, Lundemann M, Sehested A, Nysom K, Borgwardt L, Mathiasen R, Wehner PS, Henriksen OM, Thomsen C, Skjøth-Rasmussen J, Broholm H, Østrup O, Forman JL, Højgaard L, Law I.
PMID: 33864083
Neuro Oncol. 2021 Dec 01;23(12):2107-2116. doi: 10.1093/neuonc/noab096.

BACKGROUND: Central nervous system (CNS) tumors cause the highest death rates among childhood cancers, and survivors frequently have severe late effects. Magnetic resonance imaging (MRI) is the imaging modality of choice, but its specificity can be challenged by treatment-induced...

Cite
Marner L, Lundemann M, Sehested A, et al. Diagnostic accuracy and clinical impact of [18F]FET PET in childhood CNS tumors. Neuro Oncol. 2021;23(12):2107-2116doi: 10.1093/neuonc/noab096.
Marner, L., Lundemann, M., Sehested, A., Nysom, K., Borgwardt, L., Mathiasen, R., Wehner, P. S., Henriksen, O. M., Thomsen, C., Skjøth-Rasmussen, J., Broholm, H., Østrup, O., Forman, J. L., Højgaard, L., & Law, I. (2021). Diagnostic accuracy and clinical impact of [18F]FET PET in childhood CNS tumors. Neuro-oncology, 23(12), 2107-2116. https://doi.org/10.1093/neuonc/noab096
Marner, Lisbeth, et al. "Diagnostic accuracy and clinical impact of [18F]FET PET in childhood CNS tumors." Neuro-oncology vol. 23,12 (2021): 2107-2116. doi: https://doi.org/10.1093/neuonc/noab096
Marner L, Lundemann M, Sehested A, Nysom K, Borgwardt L, Mathiasen R, Wehner PS, Henriksen OM, Thomsen C, Skjøth-Rasmussen J, Broholm H, Østrup O, Forman JL, Højgaard L, Law I. Diagnostic accuracy and clinical impact of [18F]FET PET in childhood CNS tumors. Neuro Oncol. 2021 Dec 01;23(12):2107-2116. doi: 10.1093/neuonc/noab096. PMID: 33864083; PMCID: PMC8643444.
Copy Download .nbib Format: NLM
Pristine quantum criticality in a Kondo semimetal.

Science advances

Fuhrman WT, Sidorenko A, Hänel J, Winkler H, Prokofiev A, Rodriguez-Rivera JA, Qiu Y, Blaha P, Si Q, Broholm CL, Paschen S.
PMID: 34138738
Sci Adv. 2021 May 19;7(21). doi: 10.1126/sciadv.abf9134. Print 2021 May.

The observation of quantum criticality in diverse classes of strongly correlated electron systems has been instrumental in establishing ordering principles, discovering new phases, and identifying the relevant degrees of freedom and interactions. At focus so far have been insulators...

Cite
Fuhrman WT, Sidorenko A, Hänel J, et al. Pristine quantum criticality in a Kondo semimetal. Sci Adv. 2021;7(21)doi: 10.1126/sciadv.abf9134.
Fuhrman, W. T., Sidorenko, A., Hänel, J., Winkler, H., Prokofiev, A., Rodriguez-Rivera, J. A., Qiu, Y., Blaha, P., Si, Q., Broholm, C. L., & Paschen, S. (2021). Pristine quantum criticality in a Kondo semimetal. Science advances, 7(21), . https://doi.org/10.1126/sciadv.abf9134
Fuhrman, Wesley T, et al. "Pristine quantum criticality in a Kondo semimetal." Science advances vol. 7,21 (2021). doi: https://doi.org/10.1126/sciadv.abf9134
Fuhrman WT, Sidorenko A, Hänel J, Winkler H, Prokofiev A, Rodriguez-Rivera JA, Qiu Y, Blaha P, Si Q, Broholm CL, Paschen S. Pristine quantum criticality in a Kondo semimetal. Sci Adv. 2021 May 19;7(21). doi: 10.1126/sciadv.abf9134. Print 2021 May. PMID: 34138738; PMCID: PMC8133744.
Copy Download .nbib Format: NLM
The Glucagon Receptor Antagonist LY2409021 has No Effect on Postprandial Glucose in Type 2 Diabetes.

European journal of endocrinology

Hædersdal S, Lund A, Maagensen H, Nielsen-Hannerup E, Gasbjerg LS, Rosenkilde MM, Forman JL, van Hall G, Holst JJ, Knop FK, Vilsbøll T.
PMID: 34863038
Eur J Endocrinol. 2021 Dec 01; doi: 10.1530/EJE-21-0865. Epub 2021 Dec 01.

OBJECTIVE: Type 2 diabetes (T2D) pathophysiology includes fasting and postprandial hyperglucagonemia, which has been linked to hyperglycemia via increased endogenous glucose production (EGP). We used a glucagon receptor antagonist (LY2409021) and stable isotope tracer infusions to investigate consequences of...

Cite
Hædersdal S, Lund A, Maagensen H, et al. The Glucagon Receptor Antagonist LY2409021 has No Effect on Postprandial Glucose in Type 2 Diabetes. Eur J Endocrinol. 2021;doi: 10.1530/EJE-21-0865.
Hædersdal, S., Lund, A., Maagensen, H., Nielsen-Hannerup, E., Gasbjerg, L. S., Rosenkilde, M. M., Forman, J. L., van Hall, G., Holst, J. J., Knop, F. K., & Vilsbøll, T. (2021). The Glucagon Receptor Antagonist LY2409021 has No Effect on Postprandial Glucose in Type 2 Diabetes. European journal of endocrinology, . https://doi.org/10.1530/EJE-21-0865
Hædersdal, Sofie, et al. "The Glucagon Receptor Antagonist LY2409021 has No Effect on Postprandial Glucose in Type 2 Diabetes." European journal of endocrinology vol. (2021). doi: https://doi.org/10.1530/EJE-21-0865
Hædersdal S, Lund A, Maagensen H, Nielsen-Hannerup E, Gasbjerg LS, Rosenkilde MM, Forman JL, van Hall G, Holst JJ, Knop FK, Vilsbøll T. The Glucagon Receptor Antagonist LY2409021 has No Effect on Postprandial Glucose in Type 2 Diabetes. Eur J Endocrinol. 2021 Dec 01; doi: 10.1530/EJE-21-0865. Epub 2021 Dec 01. PMID: 34863038.
Copy Download .nbib Format: NLM
Multiplexing of encrypted data using fractal masks.

Optics letters

Barrera JF, Tebaldi M, Amaya D, Furlan WD, Monsoriu JA, Bolognini N, Torroba R.
PMID: 22825170
Opt Lett. 2012 Jul 15;37(14):2895-7. doi: 10.1364/OL.37.002895.

In this Letter, we present to the best of our knowledge a new all-optical technique for multiple-image encryption and multiplexing, based on fractal encrypting masks. The optical architecture is a joint transform correlator. The multiplexed encrypted data are stored...

Cite
Barrera JF, Tebaldi M, Amaya D, et al. Multiplexing of encrypted data using fractal masks. Opt Lett. 2012;37(14):2895-7doi: 10.1364/OL.37.002895.
Barrera, J. F., Tebaldi, M., Amaya, D., Furlan, W. D., Monsoriu, J. A., Bolognini, N., & Torroba, R. (2012). Multiplexing of encrypted data using fractal masks. Optics letters, 37(14), 2895-7. https://doi.org/10.1364/OL.37.002895
Barrera, John F, et al. "Multiplexing of encrypted data using fractal masks." Optics letters vol. 37,14 (2012): 2895-7. doi: https://doi.org/10.1364/OL.37.002895
Barrera JF, Tebaldi M, Amaya D, Furlan WD, Monsoriu JA, Bolognini N, Torroba R. Multiplexing of encrypted data using fractal masks. Opt Lett. 2012 Jul 15;37(14):2895-7. doi: 10.1364/OL.37.002895. PMID: 22825170.
Copy Download .nbib Format: NLM
Showing 229 to 233 of 233 entries